Skip to main content
Erschienen in: Nutrition Journal 1/2011

Open Access 01.12.2011 | Research

The role of salt abuse on risk for hypercalciuria

verfasst von: Patrícia CG Damasio, Carmen RPR Amaro, Natália B Cunha, Ana C Pichutte, José Goldberg, Carlos R Padovani, João L Amaro

Erschienen in: Nutrition Journal | Ausgabe 1/2011

download
DOWNLOAD
print
DRUCKEN
insite
SUCHEN

Abstract

Background

Elevated sodium excretion in urine resulting from excessive sodium intake can lead to hypercalciuria and contribute to the formation of urinary stones. The aim of this study was to evaluate salt intake in patients with urinary lithiasis and idiopathic hypercalciuria (IH).

Methods

Between August 2007 and June 2008, 105 lithiasic patients were distributed into 2 groups: Group 1 (n = 55): patients with IH (urinary calcium excretion > 250 mg in women and 300 mg in men with normal serum calcium); Group 2 (n = 50): normocalciuric patients (NC). Inclusion criteria were: age over 18 years, normal renal function (creatinine clearance ≥ 60 ml/min), absent proteinuria and negative urinary culture. Pregnant women, patients with intestinal pathologies, chronic diarrhea or using corticoids were excluded. The protocol of metabolic investigation was based on non-consecutive collection of two 24-hour samples for dosages of: calcium, sodium, uric acid, citrate, oxalate, magnesium and urinary volume. Food intake was evaluated by the three-day dietary record quantitative method, and the Body Mass Index (BMI) was calculated and classified according to the World Health Organization (WHO). Sodium intake was evaluated based on 24-hour urinary sodium excretion.

Results

The distribution in both groups as regards mean age (42.11 ± 10.61 vs. 46.14 ± 11.52), weight (77.14 ± 16.03 vs. 75.99 ± 15.80), height (1.64 ± 0.10 vs. 1.64 ± plusorminus 0.08) and BMI (28.78 ± 5.81 vs. 28.07 ± 5.27) was homogeneous. Urinary excretion of calcium (433.33 ± 141.92 vs. 188.93 ± 53.09), sodium (280.08 ± 100.94 vs. 200.44.93 ± 65.81), uric acid (880.63 ± 281.50 vs. 646.74 ± 182.76) and magnesium (88.78 ± 37.53 vs. 64.34 ± 31.84) was significantly higher in the IH group (p < 0.05). There was no statistical difference in calcium intake between the groups, and there was significantly higher salt intake in patients with IH than in NC.

Conclusions

This study showed that salt intake was higher in patients with IH as compared to NC.
Hinweise
An erratum to this article is available at http://​dx.​doi.​org/​10.​1186/​1475-2891-10-63.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

PCGD; CRPRA: assisted with study design; data collection, analysis and interpretation. NBC; ACP: assisted with data collection. JG: assisted with draft manuscript revision. CRP: assisted with statistical analysis. JLA: assisted with method design and manuscript writing. All authors: proofed and approved final manuscript.
Abkürzungen
IH
Hypercalciuria
NC
Normocalciuric
ml/min
millimeter per minute
BMI
Body Mass Index
VS
-Versus
g
grams
mEq
milliequivalents
WHO
World Health Organization
yrs
years
m
meter
kg
kilograms
m2
meter squared
mg/24 h
milligrams per 24 hours
n
number
%
percentage
ml/24 h
millimeter per 24 hours.

Background

Renal lithiasis is a common disease affecting nearly 20% of the world population, and in approximately 95% of cases, it is associated with a metabolic disorder [1].
Elevated sodium excretion in urine resulting from excessive sodium intake can lead to hypercalciuria and contribute to the formation of urinary stones [2]. Hypercalciuria is the metabolic disorder most frequently found in patients with urinary lithiasis [3, 4].
The World Health Organization [5] recommends that the population in general should consume less than 5 grams/day of salt that is 2 g of Na+, in order to prevent cardiovascular problems such as arterial hypertension, coronary heart disease and stroke. For lithiasic patients, salt intake should be less than 9 grams/day [6]. However, there are no studies evaluating the isolated role played by sodium restriction in the risk for lithogenesis in patients with hypercalciuria.
Food intake evaluation, and of sodium in particular, will provide information for counseling lithiasic patients, thus enabling individualized treatment in order to prevent stone recurrence in the long term.
The aim of this study was to evaluate salt intake in patients with urinary lithiasis and idiopathic hypercalciuria (IH).

Methods

From August 2007 to June 2008, 105 lithiasic patients were prospectively studied at the Outpatient Clinic of Renal Lithiasis Metabolism of the Botucatu University Hospital, Unesp. This study was approved by the Bioethics Commission of the School of Medicine - UNESP, Botucatu
Inclusion criteria were: age over 18 years, normal renal function (creatinine clearance ≥ 60 ml/min), absence of proteinuria and negative uroculture at the moment of evaluation. Creatinine clearance was calculated by using the Cockcroft-Gault formula [7]. Pregnant women, patients with intestinal pathologies, chronic diarrhea or using corticoids and diuretics were excluded.
The metabolic investigation protocol consisted of non-consecutive collection of two samples of 24-hour urine for dosages of calcium, sodium, uric acid, citrate, oxalate, magnesium and urinary volume.
The patients were distributed into two groups. Idiopathic hypercalciuria (IH) was considered to be urinary excretion of calcium > 250 mg for women and 300 mg for men with normal serum calcium. Group 1 (n = 55): patients with IH; Group 2 (n = 50): patients with normal urinary excretion of calcium (normocalciuric - NC).
Dietary intake of calcium was calculated by using the three-day dietary record quantitative method and the NutWin software (2002) [8, 9]. The measurement of 24-hour urinary sodium excretion is considered to be the gold standard method for data obtained from sodium intakes in population surveys [5]. This method has the advantage of being unaffected by subjective reporting of dietary intakes. Salt intake was estimated by [5]:
Salt intake  ( g ) = Na +  excretion  ( mEq /  24 hour urine ) 17
(1 g of salt = 17 mEq amount of sodium).
The Body Mass Index (BMI) was calculated and classified according to the World Health Organization [10].
Student's t test was used for independent samples to compare the groups of patients with calcium and non-calcium urinary lithiasis in relation to the quantitative variables studied when the variable presented adherence to the Gaussian distribution; and the Wilcoxon-Mann Whitney non-parametric test was used in cases of non-adherence. Considering the study of the association between pairs of variables, Pearson's linear correlation was used [11]. Relative risk was calculated by multiple logistic-regression analysis [12]. Differences were considered significant for p value < 0.05.

Results

Among the 105 patients studied, there was homogeneous distribution in both groups regarding mean age, weight, height and BMI. However, it was observed that, on average, according to BMI, patients in both groups were overweight (Table 1).
Table 1
Description of the median and standard deviation for age, weight, height and BMI in the different groups studied.
 
Group
 
Studied
parameters
IH (n = 55)
NC (n = 50)
P value
Age (yrs)
42.11 ± 10.61
46.14 ± 11.52
0.064
Weight (kg)
77.14 ± 16.03
75.99 ± 15.80
0.712
Height (m)
1.64 ± 0.10
1.64 ± 0.08
0.794
BMI (kg/m²)
28.78 ± 5.81
28.07 ± 5.27
0.514
Males [n (%)]
22 (40)
22 (44)
0.675
The mean urinary excretion of sodium, uric acid and magnesium was significantly higher in the IH group than in NC (Table 2).
Table 2
Description of the median and standard deviation for the biochemical characteristics of 24-hour urine in the different groups studied.
 
Group
 
Urinary
Excretion
IH (n = 55)
NC (n = 50)
P value
Calcium (mg/24 h)
433.33 ± 141.92
188.93 ± 53.09
< 0.001
Sodium (mEq/24 h)
280.08 ± 100.94
200.44 ± 65.81
< 0.001
Uric acid (mg/24 h)
880.63 ± 281.50
646.74 ± 182.76
< 0.001
Magnesium (mg/24 h)
88.78 ± 37.53
64.34 ± 31.84
< 0.001
Citrate (mg/24 h)
563.64 ± 505.45
454.89 ± 361.98
0.211
Oxalate (mg/24 h)
34.57 ± 23.41
42.40 ± 28.10
0.122
Volume (ml/24 h)
1433.5 ± 474.8
1314.4 ± 392.4
0.166
There was no statistical difference in calcium intake between the groups (Table 3).
Table 3
Description of the median and standard deviation for the composition of daily dietary intake in the different groups studied.
 
Group
 
Nutrient
IH (n = 55)
NC (n = 50)
P value
Calcium (mg)
520.13 ± 245.62
531.44 ± 299.48
0.832
Salt (g)*
16.47 ± 5.93
11.79 ± 3.87
< 0.001
* Based on 24-hour urine
Significantly higher salt intake was observed in patients with IH than in NC (Table 3). However, no association was found between urinary excretion of sodium and calcium in both groups. In NC, salt intake was higher than the amount recommended by WHO [5].
The logistic regression analysis of risk for hypercalciuria in relation to salt intake showed a chance of hypercalciuria that was 3-fold higher in patients whose salt consumption was > 9 g/day.

Discussion

Urinary lithiasis affects mainly young people in their reproductive period of life, and its control through eating habit changes is important. Epidemiological studies show that the disease is more prevalent in males [13, 14]; however, similar studies to ours do not show such remarkable differences regarding gender [1517]. Our findings are in accordance with the literature and can be explained by the higher female prevalence in the general population.
There was homogeneous distribution of age, weight, height and BMI in both groups; however, overweight was prevalent in both groups. Other authors described [1822] increased incidence of lithiasis in either obese or overweight patients of both genders. In our study, it was observed that patients with lithiasis were overweight.
Studies have shown that a moderate reduction of salt intake in hypertensive patients may also decrease urinary salt excretion, blood pressure and kidney stone recurrence [23].
Calciuria induced by increased sodium intake can result from the inhibition of re-absorbency of calcium in the proximal tubule [23, 24]. Such calciuria increases nearly 40 mg/100 mEq of supplemental sodium in normal adults' diet, and up to 80 mg in patients with hypercalciuria and urinary stones [25].
Significantly higher salt intake was observed in patients with IH, and if the amount (< 5 g salt/day) recommended by WHO [5] is considered, there was increased salt intake in the NC group, which can be determinant in the genesis of cardiovascular diseases. In a randomized trial, Borghi et al. [26] observed that sodium and animal protein restriction cause reduction in urinary calcium excretion. Curhan et al. [27] observed a significant correlation between salt intake and recurrence of kidney stones in women. In both groups in this study, higher salt intake than the recommended by WHO [5] was observed. On the other hand, other authors [20, 2830] observed increased urinary excretion of calcium related to higher sodium intake in normocalciuric patients, which shows that sodium intake control plays an important role in the genesis of lithiasis. In a randomized control trial, Nouvenne et al. [31] observed that, in some patients, salt intake decrease was associated with a slight reduction in calciuria. This fact can be explained by the fact that there are salt-dependent and salt-independent hypercalciuric patients [32].
This study will allow an effective attitude towards the control of salt intake, particularly in patients with IH. For this group of patients, the fact that increased liquid consumption associated with dietary counseling and drug therapy will provide clinical control of the lithiasic disease is also noteworthy.

Conclusion

This study showed that salt intake was higher in patients with IH as compared to NC.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Competing interests

The authors declare that they have no competing interests.

Authors' contributions

PCGD; CRPRA: assisted with study design; data collection, analysis and interpretation. NBC; ACP: assisted with data collection. JG: assisted with draft manuscript revision. CRP: assisted with statistical analysis. JLA: assisted with method design and manuscript writing. All authors: proofed and approved final manuscript.
Literatur
1.
Zurück zum Zitat Heilberg IP, Schor N, Santos DR, Cheidde L, Noronha I, Duarte RJ, Brito AH, Mitre AI, Dénes FT, Barata HS: Diretrizes de litíase urinária da sociedade brasileira de nefrologia. J Bras Nefrol. 2002, 24: 2003-2007. Heilberg IP, Schor N, Santos DR, Cheidde L, Noronha I, Duarte RJ, Brito AH, Mitre AI, Dénes FT, Barata HS: Diretrizes de litíase urinária da sociedade brasileira de nefrologia. J Bras Nefrol. 2002, 24: 2003-2007.
2.
Zurück zum Zitat Timio F, Kerry SM, Anson KM, Eastwood JB, Cappucio FP: Calcium urolithiasis, blood pressure and salt intake. Blood Press. 2003, 12: 122-127. 10.1080/08037050310001084.CrossRefPubMed Timio F, Kerry SM, Anson KM, Eastwood JB, Cappucio FP: Calcium urolithiasis, blood pressure and salt intake. Blood Press. 2003, 12: 122-127. 10.1080/08037050310001084.CrossRefPubMed
3.
Zurück zum Zitat Amaro CRPR, Amaro JL, Goldberg J: Comportamento do magnésio urinário em pacientes com litíase renal. J Bras Nefrol. 2005, 27: 146-149. Amaro CRPR, Amaro JL, Goldberg J: Comportamento do magnésio urinário em pacientes com litíase renal. J Bras Nefrol. 2005, 27: 146-149.
4.
Zurück zum Zitat Chula DC, Campos RP, Nascimento DE, Carvalho M: Caracterização clínica dos pacientes com hipercalciúria na nefrolitíase. J Bras Nefrol. 2006, 2: 72-76. Chula DC, Campos RP, Nascimento DE, Carvalho M: Caracterização clínica dos pacientes com hipercalciúria na nefrolitíase. J Bras Nefrol. 2006, 2: 72-76.
6.
Zurück zum Zitat Baxmann AC, Marques NC, Menon VB, Heilberg IP: Nutrição do paciente com nefrolitíase. Nefrologia no consultório. Edited by: Barros E, Gonçalves LF. 2007, São Paulo: Artmed, 475-483. Baxmann AC, Marques NC, Menon VB, Heilberg IP: Nutrição do paciente com nefrolitíase. Nefrologia no consultório. Edited by: Barros E, Gonçalves LF. 2007, São Paulo: Artmed, 475-483.
7.
Zurück zum Zitat Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron. 1976, 16: 31-41. 10.1159/000180580.CrossRefPubMed Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron. 1976, 16: 31-41. 10.1159/000180580.CrossRefPubMed
8.
Zurück zum Zitat Burke BS: The dietary history as a tool in research. J Am Diet Assoc. 1947, 23: 1041-1046. Burke BS: The dietary history as a tool in research. J Am Diet Assoc. 1947, 23: 1041-1046.
9.
Zurück zum Zitat Willett WC: Nutritional epidemiology. Modern epidemiology. Edited by: Rothman KJ, Greenland S. 1998, Philadelphia; Lippincott-Raven Publishers, 623-642. Willett WC: Nutritional epidemiology. Modern epidemiology. Edited by: Rothman KJ, Greenland S. 1998, Philadelphia; Lippincott-Raven Publishers, 623-642.
11.
Zurück zum Zitat Zar JH: Biostatistical analysis. 1999, New Jersey: Prentice-Hall, 663-4 Zar JH: Biostatistical analysis. 1999, New Jersey: Prentice-Hall, 663-4
12.
Zurück zum Zitat Hosmer DW, Lemeshow S: Applied survival analysis: regression modeling of time to event data. 1999, New York: John Willey & Sons, Inc, 299. Hosmer DW, Lemeshow S: Applied survival analysis: regression modeling of time to event data. 1999, New York: John Willey & Sons, Inc, 299.
13.
14.
Zurück zum Zitat Pérez FMA, Calderón JG, Herrero JV, Borros GC, Oltra AO, Bisono JRS: Epidemiología de la litiasis urinaria. Actas Urol Esp. 2001, 25: 341-349.CrossRef Pérez FMA, Calderón JG, Herrero JV, Borros GC, Oltra AO, Bisono JRS: Epidemiología de la litiasis urinaria. Actas Urol Esp. 2001, 25: 341-349.CrossRef
15.
Zurück zum Zitat Ayusso LL, Schor N: Avaliação de pacientes com litíase renal em região de clima quente. J Bras Nefrol. 2001, 23: 205-212. Ayusso LL, Schor N: Avaliação de pacientes com litíase renal em região de clima quente. J Bras Nefrol. 2001, 23: 205-212.
16.
Zurück zum Zitat Martín JAL, García JRR, Castro SN, Gómez IR, Rosado EF, Castelo LA: Factores de riesgo metabólico em urolitiasis cálcica según el sexo y edad de los pacientes. Actas Urol Esp. 2006, 26: 111-120.CrossRef Martín JAL, García JRR, Castro SN, Gómez IR, Rosado EF, Castelo LA: Factores de riesgo metabólico em urolitiasis cálcica según el sexo y edad de los pacientes. Actas Urol Esp. 2006, 26: 111-120.CrossRef
17.
Zurück zum Zitat Amaro CRPR, Goldberg J, Amaro JL, Padovani CR: Metabolic Assessment in Patients with Urinary Lithiasis. Int Braz J Urol. 2005, 31: 29-33.CrossRefPubMed Amaro CRPR, Goldberg J, Amaro JL, Padovani CR: Metabolic Assessment in Patients with Urinary Lithiasis. Int Braz J Urol. 2005, 31: 29-33.CrossRefPubMed
18.
Zurück zum Zitat Martini LA, Heilberg IP, Cuppari L, Medeiros FAM, Draibe AS, Ajzen H, Schor N: Dietary habits of calcium stone formers. Braz J Med Biol Res. 1993, 26: 805-812.PubMed Martini LA, Heilberg IP, Cuppari L, Medeiros FAM, Draibe AS, Ajzen H, Schor N: Dietary habits of calcium stone formers. Braz J Med Biol Res. 1993, 26: 805-812.PubMed
19.
Zurück zum Zitat Siener R, Glatz S, Nicolay C, Hesse A: The role of overweight and obesity in calcium oxalate stone formation. Obes Res. 2004, 12: 106-113. 10.1038/oby.2004.14.CrossRefPubMed Siener R, Glatz S, Nicolay C, Hesse A: The role of overweight and obesity in calcium oxalate stone formation. Obes Res. 2004, 12: 106-113. 10.1038/oby.2004.14.CrossRefPubMed
20.
Zurück zum Zitat Siener R, Schade N, Nicolay C, Unruh GE, Hesse A: The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol. 2005, 173: 1601-1605. 10.1097/01.ju.0000154626.16349.d3.CrossRefPubMed Siener R, Schade N, Nicolay C, Unruh GE, Hesse A: The efficacy of dietary intervention on urinary risk factors for stone formation in recurrent calcium oxalate stone patients. J Urol. 2005, 173: 1601-1605. 10.1097/01.ju.0000154626.16349.d3.CrossRefPubMed
21.
Zurück zum Zitat Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, Albala DM, Preminger GM: Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol. 2004, 172: 159-163. 10.1097/01.ju.0000128574.50588.97.CrossRefPubMed Ekeruo WO, Tan YH, Young MD, Dahm P, Maloney ME, Mathias BJ, Albala DM, Preminger GM: Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients. J Urol. 2004, 172: 159-163. 10.1097/01.ju.0000128574.50588.97.CrossRefPubMed
22.
Zurück zum Zitat Taylor EN, Stampfer MJ, Curhan GC: Obesity, weight gain and the risk of kidney stones. JAMA. 2005, 293: 455-462. 10.1001/jama.293.4.455.CrossRefPubMed Taylor EN, Stampfer MJ, Curhan GC: Obesity, weight gain and the risk of kidney stones. JAMA. 2005, 293: 455-462. 10.1001/jama.293.4.455.CrossRefPubMed
23.
Zurück zum Zitat Timio F, Kerry SM, Anson KM, Eastwood JB, Cappuccio FP: Calcium urolithiasis, blood pressure and salt intake. Blood Press. 2003, 12: 122-127. 10.1080/08037050310001084.CrossRefPubMed Timio F, Kerry SM, Anson KM, Eastwood JB, Cappuccio FP: Calcium urolithiasis, blood pressure and salt intake. Blood Press. 2003, 12: 122-127. 10.1080/08037050310001084.CrossRefPubMed
24.
Zurück zum Zitat Chula DC, Campos RP, Nascimento DE, Carvalho M: Caracterização clínica dos pacientes com hipercalciúria na nefrolitíase. J Bras Nefrol. 2006, 2: 72-76. Chula DC, Campos RP, Nascimento DE, Carvalho M: Caracterização clínica dos pacientes com hipercalciúria na nefrolitíase. J Bras Nefrol. 2006, 2: 72-76.
25.
Zurück zum Zitat Massey LK, Whiting SJ: Dietary salt, urinary calcium and kidney stone risk. Nutr Rev. 1995, 53: 131-139. 10.1111/j.1753-4887.1995.tb01536.x.CrossRefPubMed Massey LK, Whiting SJ: Dietary salt, urinary calcium and kidney stone risk. Nutr Rev. 1995, 53: 131-139. 10.1111/j.1753-4887.1995.tb01536.x.CrossRefPubMed
26.
Zurück zum Zitat Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A: Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002, 346: 77-84. 10.1056/NEJMoa010369.CrossRefPubMed Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A: Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002, 346: 77-84. 10.1056/NEJMoa010369.CrossRefPubMed
27.
Zurück zum Zitat Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ: Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997, 126: 497-504.CrossRefPubMed Curhan GC, Willett WC, Speizer FE, Spiegelman D, Stampfer MJ: Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk for kidney stones in women. Ann Intern Med. 1997, 126: 497-504.CrossRefPubMed
28.
Zurück zum Zitat Martini LA, Cuppari L, Colugnati FA, Sigulem DM, Szejnfeld VL, Schor N: High sodium chloride intake is associated with low bone density in calcium stone-forming patients. Clin Nephrol. 2000, 54: 85-93.PubMed Martini LA, Cuppari L, Colugnati FA, Sigulem DM, Szejnfeld VL, Schor N: High sodium chloride intake is associated with low bone density in calcium stone-forming patients. Clin Nephrol. 2000, 54: 85-93.PubMed
29.
Zurück zum Zitat Moe OW, Preisig PA: Hypothesizing on the evolutionary origins of salt-induced hypercalciuria. Curr Opin Nephrol Hypertens. 2005, 14: 368-372. 10.1097/01.mnh.0000172724.29628.73.CrossRefPubMed Moe OW, Preisig PA: Hypothesizing on the evolutionary origins of salt-induced hypercalciuria. Curr Opin Nephrol Hypertens. 2005, 14: 368-372. 10.1097/01.mnh.0000172724.29628.73.CrossRefPubMed
30.
Zurück zum Zitat Heilberg IP, Weisinger JR: Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens. 2006, 15: 394-402. 10.1097/01.mnh.0000232880.58340.0c.CrossRefPubMed Heilberg IP, Weisinger JR: Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens. 2006, 15: 394-402. 10.1097/01.mnh.0000232880.58340.0c.CrossRefPubMed
31.
Zurück zum Zitat Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, Soldati L, Gambaro G, Maggiore U, Borghi L: Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. 2010, 91: 565-570. 10.3945/ajcn.2009.28614.CrossRefPubMed Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, Soldati L, Gambaro G, Maggiore U, Borghi L: Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. 2010, 91: 565-570. 10.3945/ajcn.2009.28614.CrossRefPubMed
32.
Zurück zum Zitat Z Burtis WJ, Gay L, Insogna KL, Ellison A, Broadus AE: Dietary hypercalciuria in patients with calcium oxalate kidney stones. Am J Clin Nutr. 1994, 60: 424-429. Z Burtis WJ, Gay L, Insogna KL, Ellison A, Broadus AE: Dietary hypercalciuria in patients with calcium oxalate kidney stones. Am J Clin Nutr. 1994, 60: 424-429.
Metadaten
Titel
The role of salt abuse on risk for hypercalciuria
verfasst von
Patrícia CG Damasio
Carmen RPR Amaro
Natália B Cunha
Ana C Pichutte
José Goldberg
Carlos R Padovani
João L Amaro
Publikationsdatum
01.12.2011
Verlag
BioMed Central
Erschienen in
Nutrition Journal / Ausgabe 1/2011
Elektronische ISSN: 1475-2891
DOI
https://doi.org/10.1186/1475-2891-10-3

Weitere Artikel der Ausgabe 1/2011

Nutrition Journal 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.